Interleukin-9 Human Recombinant, IL 9 Human, 10ug

CAT No.BT-CYT-348

Interleukin-9 Human Recombinant, IL 9 Human, 10ug

---

Amino acid sequence
The sequence of the first five N-terminal amino acids was determined and was found to be Met-Gln-Gly-Cys-Pro.

Biological Activity
The ED50 as determined by the dose-dependant stimulation of human MO7e cells is < 0.2 ng/ml, corresponding to a Specific Activity of 5MIU/mg.

Description
Interleukin-9 Human Recombinant produced in E.Coli is a single, non-glycosylated single polypeptide chain containing 127amino acids and having a molecular mass of 14,004 Dalton.
The IL-9 is purified by proprietary chromatographic techniques.

Lyophilized from a concentrated (1mg/ml) solution containing no additives.

Physical Appearance
Sterile Filtered White lyophilized (freeze-dried) powder.

Purity
Greater than 98.0% as determined by(a) Analysis by RP-HPLC.
(b) Analysis by SDS-PAGE.

Solubility
It is recommended to reconstitute the lyophilized Interleukin-9 in sterile 18M¦¸-cm H2O not less than 100ug/ml, which can then be further diluted to other aqueous solutions.

Source
Escherichia Coli.

Stability
Lyophilized Interleukin-9 although stable at room temperature for 3 weeks, should be stored desiccated below -18¡ãC. Upon reconstitution IL9 should be stored at 4¡ãC between 2-7 days and for future use below -18¡ãC.
For long term storage it is recommended to add a carrier protein (0.1% HSA or BSA).
Please prevent freeze-thaw cycles.

Synonyms
P40, HP40, T-cell growth factor p40, IL-9, P40 cytokine.

Usage
TSZGENE's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.